The chemical activators of SmB function through intricate cellular signaling cascades to enhance its activity in RNA processing and splicing events. Forskolin serves as a pivotal activator by stimulating adenylyl cyclase, which catalyzes the conversion of ATP to cAMP, leading to the activation of PKA. This cascade results in the phosphorylation of various substrates that are crucial for SmB's role in RNA splicing, thus indirectly enhancing its activity. Epigallocatechin gallate (EGCG) contributes to the functional enhancement of SmB through the inhibition of certain kinases, which might otherwise phosphorylate substrates in a manner that competes with the activity of SmB, thereby ensuring an optimal phosphorylation state for SmB's function. Similarly, PMA activates PKC, which may phosphorylate and thus enhance the action of SmB in spliceosomal complex assembly, while LY294002's inhibition of PI3K could modulate the AKT signaling pathway, influencing the phosphorylation state of RNA processing proteins and indirectly enhancing SmB activity.
In concert with these, Ionomycin raises intracellular calcium levels, which may impact the calcium-dependent kinases and phosphatases that regulate SmB activity, while Thapsigargin, by disrupting calcium homeostasis, indirectly promotes SmB's role in cellular processes dependent on calcium signaling. Staurosporine, by inhibiting a broad spectrum of protein kinases, could release SmB from inhibitory phosphorylations, thus indirectly increasing its functional capacity. Anisomycin and U0126, through activation of JNK and inhibition of MEK1/2 respectively, may alter phosphorylation patterns that favor SmB's activity in mRNA processing. Sphingosine-1-phosphate, by acting on G-protein coupled receptors, could initiate signaling cascades that enhance SmB's role in RNA splicing. Conversely, db-cAMP, as a cAMP analog, and Bisindolylmaleimide I, through PKC inhibition, might activate alternative pathways to indirectly augment SmB's phosphorylation state and functionality, showcasing how diverse biochemical modulations converge to regulate the activity of SmB within its specific cellular milieu.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, which increases intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate and enhance the activity of SmB by facilitating its role in RNA processing. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits multiple kinases, reducing competitive signaling and thereby indirectly supporting the RNA-binding activity of SmB by maintaining the phosphorylation state required for its optimal activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels. This upsurge in calcium can modulate the calcium-dependent phosphorylation processes, indirectly enhancing the functional performance of SmB in splicing events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can phosphorylate substrates including those related to the splicing machinery, potentially enhancing the activity of SmB in its role in spliceosomal complex assembly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters AKT signaling, thereby possibly affecting the phosphorylation state of proteins associated with RNA processing and indirectly increasing the functional activity of SmB. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages with G-protein coupled receptors and can initiate signaling cascades that modulate cellular functions including RNA splicing, potentially enhancing the role of SmB within these processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, may selectively relieve the inhibitory phosphorylation on proteins interacting with SmB, thus indirectly enhancing SmB's activity in its associated pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as a JNK activator which can lead to altered phosphorylation patterns in the cell, potentially impacting the activity of SmB in mRNA splicing and regulation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that diffuses into cells and activates PKA. PKA can then phosphorylate proteins involved in mRNA processing, potentially enhancing the activity of SmB. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that could lead to the activation of alternative pathways that may enhance the phosphorylation state and functional activity of SmB. | ||||||